⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

September 16, 2024

Supplemental Figure 1 from Transcriptomic Signatures of MSI-high Metastatic Colorectal Cancer Predict Efficacy of Immune Checkpoint Inhibitors

Claire Gallois Matteo Landi Julien Taı̈eb Marine Sroussi Bahar Saberzadeh-Ardestani Antoine Cazelles Sara Lonardi Francesca Bergamo Rossana Intini Giulia Maddalena Filippo Pietrantonio Francesca Corti Margherita Ambrosini Antonia Martinetti Marco Maria Germani Chiara Boccaccio Guglielmo Vetere Sophie Mouillet‐Richard Aurélien de Reyniès Frank A. Sinicrope Chiara Cremolini Pierre Laurent‐Puig

View Full Paper

Ask AI

Bookmark

Share

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Abstract

Selection of the transcriptomic signatures for the unsupervised clustering

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Gallois et al. (2024) studied this question.

synapsesocial.com/papers/68e586c1b6db6435875238df https://doi.org/10.1158/1078-0432.27033142.v1

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Supplemental Figure 1 from Transcriptomic Signatures of MSI-high Metastatic Colorectal Cancer Predict Efficacy of Immune Checkpoint Inhibitors2024
2Supplemental Figure 4 from Transcriptomic Signatures of MSI-high Metastatic Colorectal Cancer Predict Efficacy of Immune Checkpoint Inhibitors2024
3Supplemental Figure 4 from Transcriptomic Signatures of MSI-high Metastatic Colorectal Cancer Predict Efficacy of Immune Checkpoint Inhibitors2024
4Supplemental Figure 2 from Transcriptomic Signatures of MSI-high Metastatic Colorectal Cancer Predict Efficacy of Immune Checkpoint Inhibitors2024
5Supplemental Figure 2 from Transcriptomic Signatures of MSI-high Metastatic Colorectal Cancer Predict Efficacy of Immune Checkpoint Inhibitors2024